Triple
T19773535
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Allergan |
E474948
|
entity |
| Predicate | product |
P490
|
FINISHED |
| Object | Restasis |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Restasis | Statement: [Allergan, product, Restasis]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Restasis Context triple: [Allergan, product, Restasis]
-
A.
Lucentis
Lucentis is a prescription anti-VEGF biologic drug used to treat several serious eye diseases, including wet age-related macular degeneration and diabetic macular edema, by inhibiting abnormal blood vessel growth in the retina.
-
B.
Eylea
Eylea is a widely used injectable drug for treating retinal diseases such as wet age-related macular degeneration by inhibiting vascular endothelial growth factor (VEGF).
-
C.
Xalatan
Xalatan is a widely used prescription eye drop medication (latanoprost) for lowering intraocular pressure in conditions such as glaucoma and ocular hypertension.
-
D.
Procopia
Procopia was a Byzantine noblewoman of the 9th century, known primarily as the mother of Patriarch Ignatios of Constantinople and a member of the imperial family.
-
E.
Kalydeco
Kalydeco is a prescription medication used to treat certain forms of cystic fibrosis by improving the function of defective CFTR proteins.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Restasis Target entity description: Restasis is a prescription ophthalmic cyclosporine eye drop used to increase tear production in patients with chronic dry eye disease.
-
A.
Lucentis
Lucentis is a prescription anti-VEGF biologic drug used to treat several serious eye diseases, including wet age-related macular degeneration and diabetic macular edema, by inhibiting abnormal blood vessel growth in the retina.
-
B.
Eylea
Eylea is a widely used injectable drug for treating retinal diseases such as wet age-related macular degeneration by inhibiting vascular endothelial growth factor (VEGF).
-
C.
Xalatan
Xalatan is a widely used prescription eye drop medication (latanoprost) for lowering intraocular pressure in conditions such as glaucoma and ocular hypertension.
-
D.
Procopia
Procopia was a Byzantine noblewoman of the 9th century, known primarily as the mother of Patriarch Ignatios of Constantinople and a member of the imperial family.
-
E.
Kalydeco
Kalydeco is a prescription medication used to treat certain forms of cystic fibrosis by improving the function of defective CFTR proteins.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e51a43a08190956bc6df13c91a77 |
completed | April 10, 2026, 11:55 a.m. |
| NER | Named-entity recognition | batch_69e6535e450c8190a2628245ae0d0bd3 |
completed | April 20, 2026, 4:25 p.m. |
Created at: April 10, 2026, 1:48 p.m.